40 /100
MEDIUM RISK
Score updated Jul 13, 2026

MBAV — M3-Brigade Acquisition V Corp. Dilution Risk Tracker

Track MBAV dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track MBAV — Get alerts when the score changes →

As of July 13, 2026, M3-Brigade Acquisition V Corp. (MBAV) has a DilutionWatch DilutionScore of 40/100, rated MEDIUM dilution risk. M3-Brigade Acquisition V Corp. has a market capitalization of $388.48M, 28.75M shares outstanding, 49 institutional holders tracked.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
42
💰 Cash Runway
40
📊 Float Risk
40
⚠️ Warrant Exposure
40
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for MBAV.
🔔 Track MBAV — Get forecast alerts →

💹 Market Data

Market Cap$388.48M
Shares Outstanding28.75M
Float15.36M
CashN/A
Debt$2.50M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↓ 27.0% shares (2026Q1 vs prior)
49 institutional holders · 27.62M shares
#1 METEORA CAPITAL, LLC 3.89M shares
#2 Polar Asset Management Partners Inc. 3.81M shares
#3 Jain Global LLC 2.85M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest316.9K
Days to Cover1.0
% of Float2.1%
FINRA data as of Jun 30, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Mar 31, 2026
Full SEC filing analysis available with free account

📰 Recent News

No recent news

📋 What This Means for MBAV Shareholders

M3-Brigade Acquisition V Corp. (MBAV) has a DilutionScore of 40/100, rated Medium dilution risk. This tier indicates some dilution exposure — often an older shelf registration with remaining capacity, warrants not yet exercised, or a cash position that will require monitoring over the next several quarters. Score as of July 13, 2026.

DilutionWatch's EDGAR monitoring for MBAV shows no major active dilution programs at this time. The primary risk categories — shelf registration capacity, ATM programs, warrant overhang, and cash runway — are each within normal ranges for a company of this profile. This can change quickly if a new S-3 or Form S-1 is filed.

DilutionWatch tracks over 25 SEC filing types for MBAV in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for MBAV alongside comparable medium-risk stocks. Not financial advice — this analysis is for informational purposes only.

Track MBAV Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking MBAV — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for MBAV
📊 MBAV FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 MBAV Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.